Medical Device Manufacturing – Occlusive Adhesive Dressings

The contract calls for the manufacture of sterile, occlusive adhesive dressings designed to meet rigorous military medical standards, with performance requirements centered on transparency, strong and consistent adhesion, and effective microbial barrier properties. The product specifications align with established military-grade benchmarks similar to commercial products like TEGADERM, requiring precise formulation and multi-layered construction to ensure reliability in demanding field conditions. Quality assurance protocols must validate each batch for sterility, durability, and adherence to dimensional and material specifications under varying environmental stresses. The solicitation is issued as a subcontract under the NAICS code 339113 for Medical Equipment and Supplies Manufacturing, managed by the Defense Logistics Agency on behalf of the Department of Defense. Responses are due by August 4, 2026, with the solicitation posted on July 29, 2026. Performance is expected to occur under the oversight of the DLA, though specific geographic requirements for production or delivery are not detailed. All manufacturing processes must comply with federal defense procurement standards, including stringent documentation and traceability for components, packaging, and final product validation to support deployment in military medical operations.